These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8048505)

  • 1. Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity.
    Pieber TR; Roitelman J; Lee Y; Luskey KL; Stein DT
    Am J Physiol; 1994 Jul; 267(1 Pt 1):E156-64. PubMed ID: 8048505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersecretion of amylin from the perfused pancreas of genetically obese (fa/fa) rats and its alteration with aging.
    Inoue K; Hiramatsu S; Hisatomi A; Umeda F; Nawata H
    Metabolism; 1993 May; 42(5):654-8. PubMed ID: 8492723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental regulation of amylin and insulin-gene expression in lean (Fa/Fa) and obese (fa/fa) Zucker rats.
    Koranyi L; Tanizawa Y; Penicaud L; Atef N; Girard J; Permutt MA
    Diabetes; 1992 Jun; 41(6):685-90. PubMed ID: 1375176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma amylin concentrations in fasted and fed rats quantified by a monoclonal immunoenzymometric assay.
    Vine W; Blase E; Koda J; Young A
    Horm Metab Res; 1998 Sep; 30(9):581-5. PubMed ID: 9808328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-cell tropin- and glucose-induced hypersecretion of insulin and amylin from perfused fatty rat pancreas.
    Dunmore SJ; Cawthorne MA; Hislop DC; Morton JL; Beloff-Chain A
    J Endocrinol; 1993 Jun; 137(3):375-81. PubMed ID: 8396617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma amylin and insulin concentrations in normoglycemic and hyperglycemic cats.
    Lutz TA; Rand JS
    Can Vet J; 1996 Jan; 37(1):27-34. PubMed ID: 8746416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin.
    Boyle CN; Rossier MM; Lutz TA
    Physiol Behav; 2011 Jul; 104(1):20-8. PubMed ID: 21550355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperamylinemia, hyperinsulinemia, and insulin resistance in genetically obese LA/N-cp rats.
    Huang HJ; Young AA; Koda JE; Tulp OL; Johnson MJ; Cooper GJ
    Hypertension; 1992 Jan; 19(1 Suppl):I101-9. PubMed ID: 1730446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance.
    Ye JM; Lim-Fraser M; Cooney GJ; Cooper GJ; Iglesias MA; Watson DG; Choong B; Kraegen EW
    Am J Physiol Endocrinol Metab; 2001 Apr; 280(4):E562-9. PubMed ID: 11254462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I inhibits insulin and amylin secretion in conscious rats.
    Fürnsinn C; Alma M; Roden M; Pieber T; Nowotny P; Schneider B; Waldhäusl W
    Endocrinology; 1994 Nov; 135(5):2144-9. PubMed ID: 7956938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinate regulation of amylin and insulin expression in response to hypoglycemia and fasting.
    Alam T; Chen L; Ogawa A; Leffert JD; Unger RH; Luskey KL
    Diabetes; 1992 Apr; 41(4):508-14. PubMed ID: 1607075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-37hCGRP, an amylin receptor antagonist, enhances the insulin response and perturbs the glucose response to infused arginine in anesthetized rats.
    Young AA; Carlo P; Rink TJ; Wang MW
    Mol Cell Endocrinol; 1992 Mar; 84(1-2):R1-5. PubMed ID: 1322328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human aging is associated with parallel reductions in insulin and amylin release.
    Dechenes CJ; Verchere CB; Andrikopoulos S; Kahn SE
    Am J Physiol; 1998 Nov; 275(5):E785-91. PubMed ID: 9814997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amylin tonally regulates arginine-stimulated insulin secretion in rats.
    Bennet WM; Beis CS; Ghatei MA; Byfield PG; Bloom SR
    Diabetologia; 1994 Apr; 37(4):436-8. PubMed ID: 8063047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia.
    Pieber TR; Stein DT; Ogawa A; Alam T; Ohneda M; McCorkle K; Chen L; McGarry JD; Unger RH
    Am J Physiol; 1993 Sep; 265(3 Pt 1):E446-53. PubMed ID: 8105694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cosecretion of amylin and insulin from isolated rat pancreas.
    Fehmann HC; Weber V; Göke R; Göke B; Arnold R
    FEBS Lett; 1990 Mar; 262(2):279-81. PubMed ID: 2185950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic infusion of the amylin antagonist AC 187 increases feeding in Zucker fa/fa rats but not in lean controls.
    Grabler V; Lutz TA
    Physiol Behav; 2004 May; 81(3):481-8. PubMed ID: 15135020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk.
    Kailasam MT; Parmer RJ; Tyrell EA; Henry RR; O'Connor DT
    J Hypertens; 2000 Nov; 18(11):1611-20. PubMed ID: 11081774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response for glucagonostatic effect of amylin in rats.
    Gedulin BR; Rink TJ; Young AA
    Metabolism; 1997 Jan; 46(1):67-70. PubMed ID: 9005972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats.
    Young AA; Cooper GJ; Carlo P; Rink TJ; Wang MW
    Am J Physiol; 1993 Jun; 264(6 Pt 1):E943-50. PubMed ID: 8333519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.